Home > Newsletters > Drug Industry Daily > Courts Asked to Intervene, Rule on Brand Companies’ Generic-Evading Tactics
Drug Industry Daily
July 12, 2012 | Vol. 11 No. 136
Courts Asked to Intervene, Rule on Brand Companies’ Generic-Evading Tactics
An Ohio District Court ruling that the FDA can approve generics on a withdrawn brand product could spell bad news for brand drugmakers trying to ward off generic competition.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.